Ligand‐Installed Nanocarriers: Ligand‐Installed Nanocarriers toward Precision Therapy (Adv. Mater. 13/2020),Advanced Materials

当前位置： X-MOL 学术 › Adv. Mater. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Ligand‐Installed Nanocarriers: Ligand‐Installed Nanocarriers toward Precision Therapy (Adv. Mater. 13/2020)
Advanced Materials ( IF 27.4 ) Pub Date : 2020-04-01 , DOI: 10.1002/adma.202070101
Peng Mi ₁ , Horacio Cabral ₂ , Kazunori Kataoka _{3,

4}

Affiliation

In article number 1902604, Kazunori Kataoka and co‐workers review the current state and recent achievements of ligand‐installed nanocarriers and the effect of their design on biological performance for active targeting of cancer cells, tumor vasculature, and brain and cardiovascular diseases. They also present the progress in clinical translation along with challenges and perspectives toward precision therapy.

中文翻译：

配体安装的纳米载体：用于精确治疗的配体安装的纳米载体（Adv。Mater。13/2020）

在论文1902604中，Kazunori Kataoka及其同事回顾了配体安装的纳米载体的现状和近期成就，以及它们的设计对生物学性能的影响，这些活性是癌细胞，肿瘤脉管系统以及脑和心血管疾病的有效靶标。他们还介绍了临床翻译的进展以及对精确治疗的挑战和观点。

更新日期：2020-04-01

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文本刊介绍/投稿指南11